Shoji Shimose

1.5k citations
52 papers · 1.1k indexed · h-index 18
Topics
Sarcoma Diagnosis and Treatment (26 papers)Bone Tumor Diagnosis and Treatments (15 papers)Telomeres, Telomerase, and Senescence (8 papers)
Partner nations
JapanUnited States

In The Last Decade

Shoji Shimose

49 papers receiving 1.1k citations

Peers

Shoji Shimose
Comparison fields: 5 of 90
  • Molecular Biology 454
  • Pulmonary and Respiratory Medicine 335
  • Cancer Research 249
  • Rheumatology 217
  • Biomaterials 189
Replace Tadahiko Kubo with:
Tadahiko Kubo Japan
T J Broekelmann United States
Alessandro De Vita Italy
Purva Singh United States
Wim Van de Ven Belgium
A C Nicholls United Kingdom
Shigeyuki Murono Japan
Sagar Shah United States
Hirokazu Nakahara Japan
Erich K. Odermatt Germany
Shoji Shimose relative to Tadahiko Kubo Japan Tadahiko Kubo's profile →
Citations per field
00.5×1.5×
Tadahiko Kubo · 1×
Citations per year

Countries citing papers authored by Shoji Shimose

Since Specialization
Citations

This map shows the geographic impact of Shoji Shimose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Shimose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Shimose more than expected).

Fields of papers citing papers by Shoji Shimose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoji Shimose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Shimose. The network helps show where Shoji Shimose may publish in the future.

Co-authorship network of co-authors of Shoji Shimose

This figure shows the co-authorship network connecting the top 25 collaborators of Shoji Shimose. A scholar is included among the top collaborators of Shoji Shimose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoji Shimose. Shoji Shimose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 9
3 23
4 14
5 10
6 11
7 35
8 9
9 4
10 5
11 6
12
Telomere length and telomerase activity in extra-abdominal desmoid tumors.
4
13 17
14 17
15 10
16 27
17 19
18 8
19 28
20 7

About Shoji Shimose

Shoji Shimose is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Oncology, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (26 papers), Bone Tumor Diagnosis and Treatments (15 papers) and Telomeres, Telomerase, and Senescence (8 papers). The work is most often cited by research in Cancer Research (249 citations), Biomaterials (189 citations) and Rheumatology (217 citations). Shoji Shimose has collaborated with scholars based in Japan and United States. Frequent co-authors include Mitsuo Ochi, Tadahiko Kubo, Takashi Sugita, Toshihiro Matsuo, Yuji Yasunaga, Toru Kubo, Teruo Murakami, Yoshio Kato, Shigeru Miyaki and Keisuke Shimbo. Their work appears in journals such as Blood, Journal of Bone and Joint Surgery and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026